🇺🇸 Inhaled budesonide in United States

7 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaphylactic Reaction — 1 report (14.29%)
  2. Angioedema — 1 report (14.29%)
  3. Dysphonia — 1 report (14.29%)
  4. False Positive Laboratory Result — 1 report (14.29%)
  5. Pallor — 1 report (14.29%)
  6. Skin Test Positive — 1 report (14.29%)
  7. Urticaria — 1 report (14.29%)

Source database →

Inhaled budesonide in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Inhaled budesonide approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Inhaled budesonide in United States?

Instituto Nacional de Cancerologia de Mexico is the originator. The local marketing authorisation holder may differ — check the official source linked above.